Do patients with drug‑allergy‑related angioedema have an elevated eosinophil count?

Drug-Allergy-Related Angioedema and Eosinophil Counts

No, patients with drug-allergy-related angioedema typically do NOT have elevated eosinophil counts, with the critical exception of DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms).

The Key Distinction: Mechanism Matters

The presence or absence of eosinophilia in drug-induced angioedema depends entirely on the underlying pathophysiology:

Bradykinin-Mediated Angioedema (No Eosinophilia)

The most common drug-induced angioedema—ACE inhibitor-associated angioedema—is bradykinin-mediated and does not cause eosinophilia 1. This mechanism involves:

• Impaired degradation of bradykinin due to ACE inhibition
• Increased plasma bradykinin levels
• Deep dermal and submucosal swelling without urticaria
• No eosinophil elevation

This form accounts for the majority of isolated drug-induced angioedema cases and occurs in patients taking ACE inhibitors or ARBs 1.

Histamine-Mediated Angioedema (No Eosinophilia)

When angioedema occurs with concomitant urticaria (as with NSAIDs or IgE-mediated reactions), it is histamine-mediated and also does not typically present with eosinophilia 2, 1. These reactions:

• Respond to antihistamines
• Often involve pruritus
• Are part of the chronic urticaria spectrum
• Do not show eosinophilia

The Critical Exception: DRESS Syndrome

DRESS syndrome is the major exception where drug-induced angioedema DOES present with marked eosinophilia 3, 4. This severe, delayed hypersensitivity reaction:

• Occurs 2-8 weeks after drug initiation (most commonly carbamazepine, anticonvulsants, allopurinol, sulfonamides)
• Presents with marked eosinophilia (often >8-10%) 3
• Involves multiorgan dysfunction with systemic symptoms
• Includes facial edema/angioedema as part of a broader syndrome
• Features extensive rash (often >90% body surface area)
• Shows transaminitis and other organ involvement 3, 4

Critical Diagnostic Pitfall

DRESS can masquerade as ACE inhibitor-induced angioedema when both medications are present 3. The key diagnostic clue is clinical progression despite withdrawal of the suspected agent—if angioedema and systemic symptoms worsen after stopping an ACE inhibitor, immediately consider DRESS from another concurrent medication 3.

Practical Diagnostic Algorithm

When evaluating drug-induced angioedema:

1. Check for urticaria: If present → histamine-mediated, no eosinophilia expected
2. Check medication list: ACE inhibitor/ARB present → bradykinin-mediated, no eosinophilia expected 1
3. Check timing: Symptoms 2-8 weeks after starting high-risk drug (anticonvulsants, allopurinol, sulfonamides) → consider DRESS
4. Order CBC with differential:
   • Normal eosinophils → ACE inhibitor angioedema or histamine-mediated
   • Marked eosinophilia (>8-10%) → DRESS syndrome 3
5. If eosinophilia present, check liver enzymes: Transaminitis supports DRESS 3
6. Assess extent of involvement: Isolated angioedema vs. systemic symptoms with rash

Bottom Line

Eosinophilia is NOT a feature of typical drug-induced angioedema (ACE inhibitor, ARB, or NSAID-related). However, marked eosinophilia in the setting of drug-induced angioedema should immediately raise suspicion for DRESS syndrome, which requires urgent recognition, immediate drug discontinuation, and systemic corticosteroid therapy 3, 4. The presence of eosinophilia fundamentally changes both the diagnosis and management approach.